LeCouter Jennifer, Moritz Dirk R, Li Bing, Phillips Gail Lewis, Liang Xiao Huan, Gerber Hans-Peter, Hillan Kenneth J, Ferrara Napoleone
Departments of Molecular Oncology, Protein Engineering, and Pathology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Science. 2003 Feb 7;299(5608):890-3. doi: 10.1126/science.1079562.
The vascular endothelium was once thought to function primarily in nutrient and oxygen delivery, but recent evidence suggests that it may play a broader role in tissue homeostasis. To explore the role of sinusoidal endothelial cells (LSECs) in the adult liver, we studied the effects of vascular endothelial growth factor (VEGF) receptor activation on mouse hepatocyte growth. Delivery of VEGF-A increased liver mass in mice but did not stimulate growth of hepatocytes in vitro, unless LSECs were also present in the culture. Hepatocyte growth factor (HGF) was identified as one of the LSEC-derived paracrine mediators promoting hepatocyte growth. Selective activation of VEGF receptor-1 (VEGFR-1) stimulated hepatocyte but not endothelial proliferation in vivo and reduced liver damage in mice exposed to a hepatotoxin. Thus, VEGFR-1 agonists may have therapeutic potential for preservation of organ function in certain liver disorders.
血管内皮曾被认为主要在营养物质和氧气输送中发挥作用,但最近的证据表明,它可能在组织稳态中发挥更广泛的作用。为了探究肝血窦内皮细胞(LSEC)在成年肝脏中的作用,我们研究了血管内皮生长因子(VEGF)受体激活对小鼠肝细胞生长的影响。给予VEGF-A可增加小鼠肝脏重量,但在体外不会刺激肝细胞生长,除非培养物中也存在LSEC。肝细胞生长因子(HGF)被确定为LSEC衍生的促进肝细胞生长的旁分泌介质之一。VEGF受体-1(VEGFR-1)的选择性激活在体内刺激肝细胞而非内皮细胞增殖,并减少暴露于肝毒素的小鼠的肝损伤。因此,VEGFR-1激动剂在某些肝脏疾病中可能具有保护器官功能的治疗潜力。